kbvresearch

Autoimmune Disease Therapeutics Market to reach a market size of $149.4 billion by 2025

Press release   •   Sep 23, 2019 18:50 IST

According to a new report Global Autoimmune Disease Therapeutics Market, published by KBV Research, The Global Autoimmune Disease Therapeutics Market size is expected to reach $149.4 billion by 2025, rising at a market growth of 4.34% CAGR during the forecast period.

The North America market dominated the Global Multiple Sclerosis Market by Region in 2018, growing at a CAGR of 3.9 % during the forecast period. The Europe market is expected to witness a CAGR of 4.1% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 5.9% during (2019-2025).

The Anti-Inflammatory market would dominate the Global Autoimmune Disease Therapeutics Market by Drug Class by 2025growing at a CAGR of 4.5 % during the forecast period. The Anti-Hyperglycemics market is expected to witness a CAGR of 4.7% during (2019-2025).

The Retail Pharmacies and Drug Stores market dominated the Global Autoimmune Disease Therapeutics Market by Distribution Channel in 2018, growing at a CAGR of 4.2 % during the forecast period. The Online market is expected to witness a CAGR of 4.6% during (2019-2025).

Full Report: https://www.kbvresearch.com/autoimmune-disease-therapeutics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Global Autoimmune Disease Therapeutics Market Segmentation

By Indication

Rheumatic Disease

Diabetes

Multiple Sclerosis

Inflammatory Bowel Disease

Other Indications

By Drug Class

Anti-Inflammatory

Anti-Hyperglycemics

NSAIDs

Interferons

Other Drugs

By Distribution Channel

Hospital Pharmacy

Online

Retail Pharmacies and Drug Stores

By Geography

North America

US

Canada

Mexico

Rest of North America

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

ABBOTT Laboratories

Bio-Rad Laboratories, Inc.

Johnson and Johnson

GlaxoSmithKline PLC (GSK)

Pfizer, Inc.

Merck and Co., Inc.

Bayer AG

AbbVie, Inc.

Amgen, Inc.

Novartis AG

Autoimmune Disease Therapeutics Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

Over the years, Market research has been an important component of strategic decision making processes. Market research activities have been facilitating the search for new market opportunities, understanding the market gap, bringing in the key insights into the R & D departments, value addition to marketing and promotional functions and many more. In short, one can say that the market research has been a fog light to various industries, especially while taking strategic decisions.

KBV Research is Knowledge Based Value Research, which is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals. KBV Research is a global market research and consulting company offering syndicated and custom market research reports  with exhaustive industry analysis.